Assessment of physiological changes and levels of KIM-1 and MDA Biomarkers resulting from TDM on Vancomycin-Induced Subclinical Nephrotoxicity for Pediatrics in Al-Najaf city: Case-control study
Wiadomości Lekarskie · 30.09.2026 · (9) · 2173-2179
DOI: 10.36740/wlek/231649 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Wiadomości Lekarskie, online erschienen am 30.09.2026. Verfasst von Ahmed Hasan Kadhim und 1 weiteren Autor:innen. Beteiligte Einrichtung: DEPARTMENT OF CLINICAL PHARMACY, COLLEGE OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ. Hauptthemen laut MEDLINE: Vancomycin, Drug Monitoring, Anti-Bacterial Agents, Hepatitis A Virus Cellular Receptor 1.
Abstract (Originalsprache)
Aim
Background: Among pediatric populations, Vancomycin retains its standing as a fundamental agent against severe Gram-positive infections. Nevertheless, its pharmacokinetic profile fluctuates according to developmental stage, and such inconsistency renders serum levels difficult to forecast. This lack of predictability, in turn, heightens the likelihood of therapeutic failure.
Objective
The present investigation set out to evaluate the physiological alterations together with the concentrations of the KIM-1 and MDA biomarkers as they relate to TDM-guided Vancomycin treatment. Material and methods Methodology: A prospective case-control study was undertaken at Al-Zahraa Teaching Hospital, Al-Najaf, Iraq, recruiting 140 pediatric patients receiving intravenous Vancomycin. Through random allocation, participants entered either a control arm administered conventional empirical doses n=70 or a case arm in which dosing was refined by means of pharmacist-led TDM guidance (n=70).
Results
Results: The institution of pharmacist-led therapeutic drug monitoring (TDM) markedly enhanced attainment of Vancomycin targets and promoted clinical recovery. Within the optimized-therapy group, KIM-1 concentrations declined substantially—signaling diminished renal tubular injury—whereas in those maintained on empirical therapy, these concentrations climbed. TDM-directed dose modifications further yielded a pronounced fall in MDA levels, denoting attenuated oxidative stress.
Conclusions
Conclusion: Pharmacist-led therapeutic drug monitoring bolsters both the safety and the efficacy of Vancomycin treatment in the pediatric setting. Calibrating the dose on the strength of TDM translated into superior clinical outcomes while restraining subclinical nephrotoxicity and oxidative stress, as evidenced by the pronounced decline in KIM-1 and MDA concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DEPARTMENT OF CLINICAL PHARMACY, COLLEGE OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ.
- ASSISTANT PROFESSOR OF PHYSIOLOGY, FACULTY OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ.
Zitieren
APA
Kadhim, A. H., & Ghafil, N. Y. (2026). Assessment of physiological changes and levels of KIM-1 and MDA Biomarkers resulting from TDM on Vancomycin-Induced Subclinical Nephrotoxicity for Pediatrics in Al-Najaf city: Case-control study. Wiadomości Lekarskie, 2173-2179. https://doi.org/10.36740/wlek/231649
Vancouver
Kadhim AH, Ghafil NY. Assessment of physiological changes and levels of KIM-1 and MDA Biomarkers resulting from TDM on Vancomycin-Induced Subclinical Nephrotoxicity for Pediatrics in Al-Najaf city: Case-control study. Wiadomości Lekarskie. 2026:2173-2179. doi:10.36740/wlek/231649
BibTeX
@article{Kadhim2026,
author = {Kadhim, Ahmed Hasan and Ghafil, Nagham Yahya},
title = {Assessment of physiological changes and levels of KIM-1 and MDA Biomarkers resulting from TDM on Vancomycin-Induced Subclinical Nephrotoxicity for Pediatrics in Al-Najaf city: Case-control study},
journal = {Wiadomości Lekarskie},
year = {2026},
number = {9},
pages = {2173--2179},
doi = {10.36740/wlek/231649}
}
EUVIMED